GI Day 2

Principles of Normal Nutrition and Dietary Components

• Definition of Nutrition: The physiological process involving the ingestion, breakdown, absorption, and cellular utilization of nutrients by the human body.

• Classifications of Nutritional States:

  • Normal Nutrition: Ingestion and assimilation of a balanced diet fulfilling all metabolic, energetic, and cellular maintenance demands without deficits or excesses.

  • Undernutrition: Depletion of systemic nutritional reserves occurring when daily nutritional and caloric intake fails to meet metabolic demands.

  • Overnutrition: Ingestion of nutrients and calories exceeding metabolic requirements, resulting in excess storage; widely prevalent in industrialized societies.

  • Malnutrition: An overarching pathological state comprising undernutrition, overnutrition, or nutrient imbalances (e.g., adequate caloric intake paired with severe protein deficiency).

• Essential Components of a Balanced Diet:

  • Macronutrients: Energy-yielding nutritional substrates required in substantial quantities, consisting of carbohydrates, fats, and proteins.

  • Micronutrients: Essential non-caloric compounds and elements required in minute quantities for enzymatic activity and physiological regulation, including vitamins, minerals, and electrolytes.

  • Water and Trace Elements: Fundamental systemic solvents and elemental cofactors (e.g., zinc, selenium, copper) required to support cellular metabolism.

• Carbohydrates:

  • Physiological Role: Serve as the primary, immediate fuel source for cellular respiration and daily metabolic energy.

  • Energy Density: Yields $4\,\text{kcal/g}$.

  • Protein-Sparing Effect: Adequate carbohydrate consumption prevents the catabolism of structural proteins and adipose tissue for gluconeogenesis.

  • Intake Parameters: Must constitute $45\text{ to }65\%$ of daily caloric requirements.

  • Dietary Fiber: Recommended intake is approximately $14\,\text{g}$ per day; widespread deficiency exists across Western diets due to heavy reliance on ultra-processed foods.

  • Simple Carbohydrates:

    • Monosaccharides: Single sugar units such as glucose and fructose.

    • Disaccharides: Dual-ring sugars including sucrose, maltose, and lactose.

  • Complex Carbohydrates: Polysaccharides that release energy gradually, including starches, whole grains (oatmeal, whole wheat), potatoes, and legumes.

• Fats (Lipids):

  • Physiological Role: Provide secondary, dense energy storage, insulate viscera, supply essential fatty acids, and serve as vehicles for the absorption of fat-soluble vitamins.

  • Storage Mechanism: Stored as adipose tissue; excess dietary carbohydrates are converted via hepatic lipogenesis into visceral and abdominal fat stores.

  • Intake Parameters: Must provide $20\text{ to }35\%$ of total daily caloric intake.

  • Harmful Fats:

    • Saturated Fats: Associated with atherogenesis and hyperlipidemia.

    • Trans Fats: Industrial hydrogenated oils historically found in processed snacks (e.g., Oreos) that are largely prohibited due to severe cardiovascular risks.

  • Beneficial Fats (The "MONOPOLY" Mnemonic):

    • Mnemonic used for patient dietary education combining MONOunsaturated fats (olive oil, avocados) and POLYunsaturated fats (nuts, seeds, vegetable oils).

    • Omega-3 Polyunsaturated Fatty Acids: Essential cardioprotective and neuroprotective lipids.

• Proteins:

  • Physiological Role: Primary structural components responsible for tissue growth, wound healing, cellular repair, maintenance of plasma oncotic pressure, and enzymatic/hormonal regulatory functions.

  • Intake Parameters: Must provide $10\text{ to }35\%$ of total daily caloric intake.

  • Clinical Applications: High-protein requirements are critical for healing surgical wounds, chronic ulcers, and severe thermal injuries (burn patients).

  • Amino Acid Building Blocks:

    • Nonessential Amino Acids: Compounds the liver can synthesize endogenously via transamination and intermediate metabolism.

    • Essential Amino Acids: Nine amino acids that cannot be synthesized endogenously and must be acquired through diet.

  • Dietary Sources & Vegetarian Considerations: Sourced from animal and plant proteins. Vegetarian diets must incorporate complementary proteins to prevent essential amino acid deficiencies; poor dietary habits (e.g., relying exclusively on processed macaroni and cheese) fail to deliver complete protein profiles.

• Vitamins:

  • Physiological Role: Organic cofactors required in minute quantities for cellular enzymatic pathways and metabolic function.

  • Water-Soluble Vitamins: Include Vitamin C and the B-complex group ($\text{B}_1$ thiamine, $\text{B}_2$ riboflavin, $\text{B}_3$ niacin, $\text{B}_5$ pantothenic acid, $\text{B}_6$ pyridoxine, $\text{B}_9$ folate, $\text{B}_{12}$ cobalamin). These vitamins are not stored in significant quantities, require daily dietary replenishment, and excess amounts are readily excreted through renal filtration.

  • Fat-Soluble Vitamins: Encompass Vitamins A, D, E, and K. These vitamins are absorbed alongside dietary lipids and stored in hepatic and adipose tissue. They do not require daily intake, but excessive supplemental ingestion carries a high risk of hypervitaminosis/toxicity resulting in gastrointestinal and systemic complications.

  • Vitamin D Geographic Deficiency: Regions north of Atlanta, Georgia (the Northern Hemisphere) experience insufficient ultraviolet B exposure during winter months, causing widespread, underdiagnosed Vitamin D deficiencies that necessitate supplementation.

• Culturally Competent Dietary Care:

  • Nurses must adapt nutritional plans to religious mandates, cultural customs, and ethical preferences (e.g., vegetarianism, avoidance of pork, halal, kosher standards).

  • Avoid cultural stereotyping and collaborative resistance; consult registered dietitians to formulate culturally congruent, nutritionally complete meal profiles.

• Interpretation of Food Nutrition Labels:

  • Standard United States nutritional labels display serving size (frequently mistaken for the entire container contents) and total servings per package.

  • Labels detail macronutrients (total fat, saturated fat, trans fat, poly/monounsaturated fats, total carbohydrates, dietary fiber, total protein) and micronutrients/trace elements.

  • Ingredients List Order: Ingredients are displayed in descending order of predominance by weight; the initial ingredient constitutes the highest proportion of the product, whereas the final listed ingredient represents the smallest quantity (e.g., whole wheat flour listed first versus artificial dyes listed last).

Malnutrition Pathophysiology, Classifications, and Assessment

• Classifications of Malnutrition:

  • Starvation-Related Malnutrition (Primary): Caloric and protein deprivation occurring without sustained systemic inflammation (e.g., classical anorexia nervosa, severe elder/child neglect, socioeconomically driven food deprivation).

  • Chronic Disease-Related Malnutrition (Secondary): Inadequate nutrient intake or altered assimilation secondary to underlying chronic pathologies, sustained by mild-to-moderate systemic inflammation (e.g., end-stage organ failure, malignancies, rheumatoid arthritis, sarcopenic obesity).

  • Acute Disease- or Injury-Related Malnutrition: Rapid, profound nutritional depletion induced by severe acute inflammatory insults (e.g., major burns, polytrauma, extensive surgical interventions, septicemia).

• Pathophysiological Cascade of Starvation:

  • Phase 1 (Carbohydrate Depletion): The body utilizes accessible circulating glucose and hepatic glycogen reserves to sustain basic metabolic demands; total glycogen stores are exhausted within $8\text{ to }18\,\text{hours}$.

  • Phase 2 (Skeletal Muscle Proteolysis): Following glycogen exhaustion, the body accelerates skeletal muscle breakdown via gluconeogenesis to liberate amino acids for critical glucose production. Proteolysis causes marked nitrogen excretion, resulting in elevated blood urea nitrogen levels, a negative nitrogen balance, and a wasted, cachectic physical appearance.

  • Phase 3 (Lipolysis and Fat Catabolism): Prolonged starvation forces a metabolic shift toward ketone production and adipose catabolism. Fat catabolism provides up to $97\%$ of daily energy demands, temporarily sparing deeper visceral protein pools. Adipose reserves are typically exhausted within $4\text{ to }6\,\text{weeks}$, depending on starting body composition.

  • Phase 4 (Loss of Visceral Adipose & Hepatic Impairment): Depletion of visceral adipose tissue strips internal organs (such as kidneys and bowel) of mechanical cushioning, leaving them vulnerable to trauma. The liver undergoes mass atrophy and fatty infiltration, impairing synthetic pathways.

  • Hypoalbuminemia and Fluid Compartment Shifts:

    • Hepatic protein synthesis fails, dropping serum albumin levels.

    • Loss of serum albumin reduces plasma oncotic pressure ($\pi_c$), allowing intravascular fluids to extravasate into interstitial tissues (third-spacing).

    • Clinical manifestations include peripheral dependent edema, severe ascites, pleural effusions, and pulmonary edema.

    • Anasarca: Extreme, generalized whole-body third-spacing where interstitial tissues become saturated, skin turns taut and weeping, and peripheral pitting exceeds $4\,\text{mm}$.

    • Cellular Pump Failure: Depletion of adenosine triphosphate (ATP) causes failure of the cellular $\text{Na}^+/\text{K}^+$ ATPase pump, disrupting cellular osmolarity and leading to cell lysis and organ failure.

• Albumin Replacement vs. High-Protein Diets:

  • Dietary protein replenishment requires a minimum of $3\,\text{weeks}$ to several months of therapy before measurable increases in circulating serum albumin occur.

  • Critically ill patients with profound hypoalbuminemia and anasarca cannot wait weeks for dietary conversion; administering loop diuretics alone depletes intravascular volume and triggers severe hypotension.

  • Emergency clinical management requires intravenous albumin infusions to rapidly elevate intravascular oncotic pressure, drawing interstitial fluid back into the vascular space, followed immediately by diuretic administration to excrete excess fluid.

• Systemic Inflammatory Response in Starvation:

  • Prolonged starvation triggers a cytokine cascade (release of tumor necrosis factor-alpha, interleukins), accelerating proteolysis, inducing an elevated basal metabolic rate (BMR), and accelerating glucose turnover.

  • Cytokines suppress negative acute-phase proteins (albumin, prealbumin) while markedly elevating positive acute-phase inflammatory markers such as C-Reactive Protein (CRP).

• Clinical Manifestations of Severe Malnutrition:

  • Skin, hair, and nail alterations: Skin appears dry, flaky, paper-thin, or stretched and taut from edema; hair turns sparse, brittle, and sheds easily; nails become brittle and ridged.

  • Oral cavity changes: Cheilosis, glossitis, cracked oral mucosa, dry tongue, and mucosal ulcerations.

  • Neurological & Musculoskeletal deficits: Extreme skeletal muscle wasting, profound physical weakness, delayed wound healing, severe lethargy, confusion, and peripheral neuropathy.

  • Immune Suppression: Marked leukopenia, impaired cell-mediated immunity, and high vulnerability to opportunistic systemic infections.

• Comprehensive Nutritional Assessment:

  • Dietary History: Real-time dietary diaries covering the past seven days are superior to retrospective recall.

  • Anthropometrics: Height, daily weights, and Body Mass Index (BMI). BMI serves as a hospital screening tool but possesses significant diagnostic limitations, such as misclassifying heavily muscled individuals as obese.

  • Biochemical Evaluation: Serum albumin (half-life of approximately $20\,\text{days}$, reflecting chronic status), prealbumin (half-life of $2\text{ to }4\,\text{days}$, reflecting acute protein changes), C-Reactive Protein (CRP), complete blood counts (monitoring for microcytic or macrocytic anemia), and serum electrolytes.

  • Critical Starvation Marker: Profound hypophosphatemia, alongside hypokalemia, hyponatremia, and hypomagnesemia.

  • Mini Nutritional Assessment (MNA): Validated clinical screening performed within $24\,\text{hours}$ of hospital admission. Evaluates intake decline over the preceding 3 months, unintentional weight loss, mobility restrictions, psychological distress/acute illness, neuropsychological impairment (severe dementia, depression), and BMI. Subnormal scores trigger an automatic consult to a clinical dietitian.

• Socioeconomic and Systemic Etiologies:

  • Food Insecurity: Inability to access wholesome foods, occurring in urban, suburban, and rural communities.

  • The "Heat and Eat" Phenomenon: Low-income, fixed-income, and elderly populations are frequently forced to choose between purchasing life-sustaining medications, paying basic heating/utility bills, or buying food. Skipping medications (e.g., insulin, causing life-threatening diabetic ketoacidosis; heart failure therapies, inducing acute exacerbations) results in costly, preventable emergency hospitalizations.

• Secondary Physical and Gastrointestinal Etiologies:

  • Dysphagia, odynophagia, or painful gastric ulcerations causing intentional food avoidance.

  • Intractable nausea, vomiting, and high-output diarrhea.

  • Malabsorption syndromes: Pancreatic exocrine insufficiency, celiac disease, Crohn's disease, and surgical short-bowel states (partial/total gastrectomy, colectomy, bariatric Roux-en-Y gastric bypass).

  • Hypermetabolic states: Prolonged febrile episodes significantly elevate the BMR, causing rapid caloric deficits.

  • Substance Use Disorders: Chronic alcohol use disorder leads to severe dietary neglect, caloric displacement, and severe micronutrient depletion, specifically thiamine ($\text{B}_1$), necessitating prophylactic intravenous multivitamin ("banana bag") infusions.

Enteral Nutrition (EN): Indications, Tube Types, and Access Routes

• Fundamental Guiding Principle: "If the gut works, use it." Enteral feeding utilizes an intact, functional gastrointestinal tract. Compared to parenteral feeding, enteral nutrition is more physiologically efficient, preserves gut mucosal architecture, maintains the gut barrier against bacterial translocation, is associated with fewer infectious complications, and is substantially less expensive.

• Clinical Indications for Enteral Nutrition:

  • Gastrointestinal tract remains functional, but oral intake is unsafe, impossible, or inadequate.

  • Severe anorexia secondary to systemic disease, chemoradiation, or advanced malignancy.

  • Extensive maxillofacial trauma or structural jaw fractures precluding mastication.

  • Head and neck carcinomas, both pre-operatively and post-resection/reconstruction.

  • Severe psychiatric disorders involving persistent food refusal.

  • Extensive thermal injury (burns) across the face, neck, or thorax requiring massive caloric replacement.

  • Critical illness requiring mechanical ventilation with endotracheal intubation.

  • Profound dysphagia, cranial nerve palsies, or absent protective laryngeal gag reflexes.

• Modes of Enteral Administration:

  • Continuous Infusion: Administered uninterrupted over $24\,\text{hours}$ via an automated electronic feeding pump at low, regulated rates (e.g., $40\,\text{mL/h}$); common in critical care units.

  • Intermittent / Bolus by Pump: Administration of larger formula volumes ($200\text{ to }400\,\text{mL}$) over a defined interval of $30\text{ to }60\,\text{minutes}$ using an infusion pump.

  • Intermittent / Bolus by Gravity: Formula is poured into an elevated, open syringe barrel or gravity drip bag held above the abdomen, draining solely by gravity over $15\text{ to }30\,\text{minutes}$, followed by a water flush.

  • Bolus by Syringe: Manual instillation of formula using a hand-held plunger via a $60\,\text{mL}$ catheter-tip (Toomey) syringe with steady, gentle positive pressure, followed by a water flush.

  • Nocturnal Infusions: Continuous feeds run exclusively overnight to allow active patients daytime mobility and freedom from equipment.

• Anatomical Tube Classifications:

  • Short-Term Enteral Tubes ($< 4\,\text{weeks}$ duration):

    • Nasogastric (NG) / Orogastric (OG): Extends from nares/mouth into the stomach.

    • Nasoduodenal (ND): Passes through the pylorus into the duodenum.

    • Nasojejunal (NJ): Passes past the ligament of Treitz into the jejunum.

  • Long-Term Enteral Access ($> 4\,\text{weeks}$ duration):

    • Gastrostomy Tube (G-Tube / PEG): Percutaneous Endoscopic Gastrostomy tube inserted directly through the anterior abdominal wall into the gastric lumen.

    • Jejunostomy Tube (J-Tube / PEJ): Percutaneous access terminating directly in the jejunal lumen; essential when bypassing gastric pathology, severe gastroparesis, or unresolving gastric outlet obstruction.

    • Indicated for permanent deficits, such as patients with long-term tracheostomies requiring permanent nutritional bypass ("They can trach, they can PEG").

• Specific Tube Designs and Mechanics:

  • Salem Sump Tube:

    • Rigid, double-lumen clear plastic tube designed primarily for short-term gastric decompression via wall suction, though usable for emergency administration.

    • Blue Vent Lumen ("Pigtail"): Vents the gastric lumen to atmospheric air, preventing the suction eyelets from adhering to, pulling, and ulcerating the gastric mucosa during continuous or intermittent suction.

    • Safety Rule: The blue pigtail must never be used for medication administration, feeding, or sterile water flushing. The blue vent must only interface with atmospheric air.

    • If gastric fluids reflux into the blue vent (due to siphonage below the stomach level), instill $10\text{ to }20\,\text{mL}$ of air through the vent to re-establish the air cushion.

    • When evaluating bowel motility (e.g., post-operative ileus resolution), clamp the main suction tube per order while leaving the blue vent open, observing for abdominal distention or vomiting.

  • Small Bowel Feeding Tube (SBFT):

    • Small-diameter ($8\text{ to }12\,\text{French}$), soft, flexible polyurethane tube.

    • Engineered strictly for nutrient delivery; cannot be connected to suction or used for decompression.

    • Features a primary feeding port and a secondary medication/irrigation port with distinct caps.

  • Dobhoff Tube:

    • Small-bore, highly flexible feeding tube constructed with a radiopaque tungsten-weighted tip.

    • Weight facilitates peristaltic migration through the pylorus into the duodenum/jejunum.

    • Contains an internal flexible metal stylet/guidewire to provide rigidity during insertion.

    • Safety Mandate: Once the stylet is withdrawn post-placement verification, it must never be reinserted while the tube remains within the patient due to high risks of esophageal or gastric perforation.

    • Due to perforation hazards during stylet advancement, check institutional policy; some facilities restrict Dobhoff placements to advanced practice providers or credentialed personnel.

  • Percutaneous Gastrostomy / Jejunostomy Tubes:

    • Inserted surgically, laparoscopically, fluoroscopically, or endoscopically.

    • Maintained internally via an inflated water retention balloon or mushroom bumper, and anchored externally via a bolster/retention crossbar flush against the epidermis.

    • Accidental Tube Dislodgement: If a mature G-tube is accidentally avulsed, the gastric stoma can close within hours. The nurse must never attempt blind reinsertion of a rigid G-tube (outside nursing scope). To preserve stoma patency, immediately insert a sterile Foley catheter into the tract, gently inflate the balloon, tape it securely without tension to the abdominal wall, and obtain emergency medical evaluation.

Enteral Feeding Procedures, Management, and Nursing Care

• Step-by-Step Nasogastric / Enteral Tube Insertion Procedure:

  1. Preparation & Verification: Verify provider order. Check that informed consent is documented if facility requires it. Gather supplies: correct gauge tube, water-soluble lubricant (or topical lidocaine jelly where ordered), $60\,\text{mL}$ Toomey syringe, cup of tap water with a straw, non-allergenic tape or commercial securement device, skin protectant, pH paper, and clean gloves. (Clean, non-sterile procedure).

  2. Patient Assessment: Position patient in high Fowler’s position ($90^\circ$). Inspect nares for patency; evaluate for septal deviations, history of nasal fractures, or prior nasal surgeries.

  3. Measurement Technique (NEX Measurement):

     • Measure the distance from the tip of the Nose to the Earlobe.

     • Extend the measurement down to the Xiphoid process.

     • Add an additional $3\text{ to }4\,\text{finger-breadths}$ ($5\text{ to }10\,\text{cm}$) below the xiphoid process to ensure the terminal ports reach the gastric well.

     • Note the corresponding centimeter marking on the tube shaft (e.g., $67\,\text{cm}$) or place a small piece of tape as an insertion guide.

  4. Insertion Technique:

     • Lubricate the distal $7.5\text{ to }10\,\text{cm}$ ($3\text{ to }4\,\text{inches}$) generously with water-soluble lubricant.

     • Instruct the patient to extend their neck slightly backwards; gently advance the tube along the floor of the nasal passage toward the nasopharynx.

     • Once the tube reaches the posterior pharynx, pause. Instruct the patient to drop their chin to chest (cervical flexion closes the glottis and directs the tube into the esophagus).

     • Instruct the patient to swallow small sips of water through the straw. Advance the tube sequentially with each deliberate swallow.

     • Complications during advancement: If the patient exhibits persistent coughing, gasping, cyanosis, or dyspnea, the tube has entered the trachea; immediately withdraw the tube into the posterior pharynx, allow the patient to recover, and re-attempt. If the tube coils in the mouth or exits the opposite naris, retract and redirect.

     • Advance the tube to the measured centimeter marking; temporarily secure the tube to the nose.

• Verification of Enteral Tube Placement:

  • Gold Standard: Radiographic confirmation via an anterior-posterior X-ray prior to administering any formula, medication, or fluid flush.

  • Bedside Verification Methods: Aspirate gastric secretions; observe color (green, tan, off-white, or bloody) and test with pH indicator paper (gastric aspirate pH is typically $\le 5.5$; intestinal aspirate pH is $\ge 6.0$; respiratory aspirate pH is $\ge 7.0$).

  • Obsolete / Unsafe Practice (Air Auscultation): Instilling an air bolus while auscultating over the epigastrium (the "whoosh test") is unreliable, historically obsolete, and clinically dangerous. Auscultated sounds from tubes positioned in the lung or distal esophagus can closely mimic gastric sounds. Air auscultation must never be used to confirm tube placement.

  • Subsequent Maintenance Verification: At the start of every shift, before each intermittent feed, prior to every medication pass, and every $8\,\text{hours}$ during continuous feeds, inspect the external centimeter mark at the naris and aspirate contents to verify ongoing proper positioning.

• Aspiration Prevention and Patient Positioning:

  • The head of the bed (HOB) must remain elevated to a minimum of $30\text{ to }45^\circ$ throughout continuous enteral infusions.

  • Following an intermittent or bolus feeding, the HOB must remain elevated at $30\text{ to }45^\circ$ for $30\text{ to }60\,\text{minutes}$.

  • Transport/Turning Rule: The nurse must temporarily stop the infusion, flush the line, and disconnect it before lowering the HOB flat for repositioning, hygiene care, or bed transport. A physician order is not required to pause feeds for nursing care or transport; this is an independent nursing safety mandate. Resume feeding once the HOB is returned to $\ge 30^\circ$.

• Gastric Residual Volume (GRV) Management:

  • Assess GRVs every $4\,\text{hours}$ for continuous infusions, and immediately before initiating each intermittent bolus feeding.

  • Residual Assessment Technique: Aspirate the gastric contents using a $60\,\text{mL}$ Toomey syringe until resistance is met; record the total aspirated volume.

  • Action Threshold: If the GRV exceeds $250\,\text{mL}$ on two consecutive checks, or exceeds a single threshold of $500\,\text{mL}$ (or per agency policy), hold the feeding, pause the infusion, and immediately notify the primary healthcare provider.

  • Refeeding Residuals Rule: Aspirated gastric volume must always be reinstilled back into the patient's stomach. Gastric aspirate contains concentrated hydrochloric acid, pepsin, and electrolytes (sodium, chloride, potassium). Discarding residuals depletes systemic electrolytes and triggers metabolic alkalosis. (Only discard residual if the fluid is frankly foul, purulent, or if the patient is actively vomiting).

• Tube Patency and Flushing Protocol:

  • Flush the feeding tube with $30\,\text{mL}$ of room-temperature tap or sterile water:

    • Every $4\,\text{hours}$ during continuous feedings (can be programmed into electronic pump software).

    • Before and after every intermittent or bolus feeding.

    • Before, between, and after every medication administration.

  • Resolving Clogged Enteral Tubes: If an enteral tube occludes, do not force fluids (risk of tube rupture). Administer a mixture of crushed pancreatic enzymes (Pancrelipase/Viokase) and sodium bicarbonate dissolved in warm water; instill into the tube, clamp for $20\text{ to }30\,\text{minutes}$, and gently aspirate. Never flush with Coca-Cola, Pepsi, or cranberry juice. Acidic beverages precipitate proteins out of formulas, worsening intraluminal clogs, and erode polyurethane and silicone walls over time.

• Medication Administration via Enteral Feeding Tubes:

  • Convert solid medications to liquid formulations whenever available (e.g., oral liquid acetaminophen, liquid guaifenesin).

  • Crush compatible tablets into a fine powder and dissolve individually in $15\text{ to }30\,\text{mL}$ of warm water. Administer each medication separately with a water flush between drugs.

  • Do not combine medications into a single slurry mixture (violates regulatory standards like CMS and increases risks of chemical incompatibilities).

  • Absolute Contraindications to Crushing: Enteric-coated (EC), sustained-release (SR), extended-release (ER/XL), or sublingual tablets. Crushing an enteric-coated drug (such as enteric-coated morphine) bypasses the protective coating, converting it into a lethal immediate-release dose.

  • Medications requiring independent timing: Sucralfate (Carafate) must be administered separately on an empty stomach to coat mucosal surfaces.

• Tubing and System Maintenance:

  • Administration sets (feeding bags and plastic infusion pump tubing) must be completely discarded and replaced every $24\,\text{hours}$.

  • $60\,\text{mL}$ catheter-tip Toomey syringes must be discarded and replaced every $24\,\text{hours}$.

  • Open system formula hang times must not exceed $3\text{ to }4\,\text{hours}$ to prevent bacterial proliferation.

• Prevention of Sentinel Misconnections:

  • Inadvertently connecting an enteral administration set to an intravenous access line, central catheter, peritoneal dialysis catheter, or tracheostomy cuff balloon can lead to catastrophic embolization and death.

  • Modern standards mandate the use of incompatible, non-Luer lock connector designs (ENFit).

  • Trace all lines from the insertion site to the source bag before making connections, and verify line labels at every clinical handoff.

• Complications of Enteral Nutrition:

  • Aspiration Pneumonitis: Secondary to tube displacement, regurgitation, or flat recumbent positioning.

  • Feeding Intolerance: Manifested by nausea, retching, vomiting, persistent abdominal distention, or absence of bowel sounds. Manage by slowing the infusion rate, switching to continuous feeds, or administering prokinetic agents (metoclopramide / Reglan).

  • Diarrhea: Caused by hyperosmolar formulas, rapid infusion rates, bacterial contamination, or antibiotic therapy.

  • Hypertonic Dehydration: High-protein, calorie-dense formulas pull free water into the intestinal lumen, causing osmotic diuresis. Supplement with ordered free-water flushes (e.g., $100\,\text{mL}$ flushes) to maintain hydration.

  • Dumping Syndrome: Rapid administration of hyperosmolar or cold formula directly into the jejunum causes rapid fluid shifts from circulating plasma into the intestinal lumen. Manifested by diaphoresis, facial pallor, severe hypotension, reflex tachycardia, abdominal cramping, and explosive diarrhea.

  • Peritonitis: Severe surgical complication resulting from tube displacement into the peritoneal cavity or tracking of formula into the peritoneum. Manifested by a rigid, board-like abdomen, involuntary guarding, extreme rebound tenderness, and septic shock.

Parenteral Nutrition (PN): Central vs. Peripheral Therapy

• Definition of Parenteral Nutrition: The intravenous infusion of a hypertonic, nutritionally complete liquid blend directly into the systemic circulation to sustain life when the gastrointestinal tract is non-functional, inaccessible, or impaired.

• Clinical Indications for Parenteral Nutrition:

  • Intractable, high-output vomiting and diarrhea unresponsive to medical therapies.

  • Severe, active exacerbations of inflammatory bowel disease (Crohn's disease, ulcerative colitis) requiring complete bowel rest.

  • Mechanical bowel obstruction, high-output enterocutaneous fistulas, or diffuse paralytic ileus.

  • Severe short-bowel syndrome resulting from extensive surgical resections.

  • Severe, persistent celiac disease flares refractory to gluten exclusion.

  • Profound, refractory anorexia nervosa.

  • Critically ill surgical, trauma, or burn patients who must remain completely NPO for longer than $48\,\text{hours}$ without imminent gut recovery.

• Central Parenteral Nutrition (CPN) / Total Parenteral Nutrition (TPN):

  • Nomenclature: CPN and TPN are clinically interchangeable terms designating central venous delivery.

  • Infusion Route: Must be infused exclusively through a Central Venous Access Device (CVAD) with the catheter tip terminating within the lower third of the Superior Vena Cava (SVC) at the cavoatrial junction. Accessible via internal jugular, subclavian, tunneled Hickman/Broviac lines, or Peripherally Inserted Central Catheters (PICC).

  • Tonicity & Osmolarity: Marked hypertonicity with osmolarities ranging from $1800\text{ to }2000\,\text{mOsm/L}$.

  • Vesicant Nature: Because of extreme hypertonicity and dextrose levels exceeding $20\%$ (typically $20\text{ to }50\%$), CPN is an intense chemical vesicant. Infusing CPN through a peripheral vein triggers immediate, severe endothelial damage, vein sclerosis, thrombophlebitis, and tissue necrosis. CPN must never be infused through a peripheral line.

  • Therapeutic Duration: Indicated for long-term therapy ($> 2\,\text{weeks}$) or complete, sole-source nutritional replacement.

• Peripheral Parenteral Nutrition (PPN):

  • Infusion Route: Administered through a large-bore peripheral vein or midline intravenous catheter.

  • Tonicity & Osmolarity: Moderately hypertonic, with osmolarities strictly limited to $600\text{ to }700\,\text{mOsm/L}$.

  • Composition Limits: Dextrose concentration cannot exceed $10\text{ to }20\%$ to protect peripheral venous endothelium.

  • Therapeutic Duration: Strictly short-term support ($3\text{ to }7\,\text{days}$ per week, up to $3\text{ to }4\,\text{weeks}$ maximum); often used as supplemental nutrition while an oral or enteral diet is gradually re-established.

  • Risks: High incidence of chemical phlebitis, vein tracking, and peripheral intravenous extravasation.

• Composition of Parenteral Nutrition Solutions:

  • Dextrose: Concentrated carbohydrate source providing the primary caloric value of the solution.

  • Amino Acids: Crystalline synthetic essential and nonessential amino acids providing nitrogen substrates for protein synthesis; dosed at $1.0\text{ to }1.5\,\text{g/kg/day}$ to achieve a positive nitrogen balance.

  • Micronutrient Additives: Standard additions of sodium, potassium, chloride, magnesium, calcium, and phosphorus. Individualized additions of trace elements (zinc, copper, chromium, manganese, selenium, iodine) and therapeutic multivitamins (MVI).

  • Visual Appearance: Parenteral solutions containing multivitamin additives display a bright, fluorescent yellow color (resembling "Mountain Dew"); solutions devoid of multivitamins appear clear.

  • Intravenous Fat Emulsions (IVFE / Lipids):

    • Supplies essential fatty acids and dense non-protein calories, accounting for approximately $30\%$ of total daily caloric intake.

    • Available in $10\%$, $20\%$, and $30\%$ lipid emulsion concentrations.

    • Appearance is completely opaque and milky-white.

    • Allergy Contraindication: Commercial lipid emulsions are derived from refined soybean or safflower oils and egg phospholipids; absolute contraindication in patients with severe soy or egg allergies.

• Aseptic Handling and Administration Standards:

  • Compounding: Compounded exclusively by licensed pharmacy personnel within an ISO-classified vertical laminar airflow hood using strict aseptic technique. Nurses must never inject additives into a PN bag at the bedside or on the clinical unit.

  • Refrigeration: Freshly compounded PN bags must be placed under refrigeration within $30\,\text{minutes}$ of compounding. Remove from the refrigerator $30\text{ to }60\,\text{minutes}$ prior to hanging to allow passive warming to room temperature.

  • Bag & Tubing Expiration: Due to high dextrose concentrations facilitating rapid bacterial and fungal proliferation, aqueous PN bags and tubing must be completely discarded and replaced every $24\,\text{hours}$, regardless of the volume remaining in the bag. Lipid emulsion tubing must be changed every $12\,\text{hours}$.

  • Inspection: Inspect the solution against light for particulate precipitates, gross cloudiness, or emulsion "cracking" (visible separation of fat into free oil droplets on the surface); discard immediately if abnormalities are observed.

  • Infusion Pump Rule: Parenteral solutions must always run on an electronic infusion pump. Never infuse by gravity.

• Filtration Standards:

  • Aqueous TPN / CPN / PPN: Requires an inline $0.2\text{-micron}$ particulate/bacteria-retentive filter.

  • Lipid Emulsions (IVFE): Requires an inline $1.2\text{-micron}$ filter (larger pore size prevents trapping or shearing of bulky emulsified lipid droplets).

• Infusion Titration and Discontinuation Protocols:

  • Initiation: Initiate infusion at a low rate (typically $40\text{ to }60\,\text{mL/h}$) and titrate upward by $20\,\text{mL/h}$ every $12\,\text{hours}$ until reaching the target rate (e.g., $80\,\text{mL/h}$), allowing the endocrine pancreas to adjust to the high glucose load.

  • Discontinuation: Never discontinue parenteral nutrition abruptly. Taper down gradually (e.g., reduce the rate by $50\%$ for $8\,\text{hours}$, reduce by another $50\%$ for the next $8\,\text{hours}$, then discontinue).

  • Rebound Hypoglycemia Emergency Protocol: If a TPN bag empties before the pharmacy delivers the replacement bag, never allow the line to stop or infuse plain normal saline. Immediately hang an emergency infusion of $10\%$ Dextrose in Water ($\text{D}_{10}\text{W}$) (or $5\%$ Dextrose for PPN) through the existing line at the established hourly TPN infusion rate. This provides sustained carbohydrate delivery to prevent rebound hypoglycemia until the new bag arrives.

Systemic Complications of Parenteral Nutrition and Central Line Care

• Refeeding Syndrome:

  • Etiology: A life-threatening metabolic emergency occurring when concentrated carbohydrates are reintroduced to severely malnourished, starved, or chronically cachectic patients.

  • High-Risk Populations: Patients with chronic anorexia nervosa, severe alcohol use disorder, prolonged starvation, chronic malabsorption, or ongoing chemotherapy.

  • Pathophysiological Cascade: Prolonged starvation depletes total-body intracellular ions, though baseline serum levels may appear deceptively normal. Sudden carbohydrate reintroduction triggers massive endogenous insulin secretion from the pancreas. Circulating insulin drives glucose, water, potassium, magnesium, and phosphate rapidly out of the extracellular serum into the intracellular space for protein synthesis, glycogen creation, and ATP assembly.

  • Hallmark Diagnostic Finding: Profound, precipitous hypophosphatemia.

  • Associated Shifts: Marked hypokalemia, hypomagnesemia, and excessive sodium and water retention.

  • Clinical Manifestations: Severe cardiac dysrhythmias (ventricular tachycardia, ventricular fibrillation, asystole), acute congestive heart failure, severe pulmonary edema, respiratory arrest (diaphragmatic muscle failure), profound skeletal muscle paralysis, acute delirium, seizures, coma, and death.

  • Historical Context: Clinically documented during the liberation and immediate refeeding of survivors from World War II concentration camps.

  • Clinical Prevention: Screen serum electrolytes prior to feeding initiation. Actively correct low baseline phosphorus levels with oral or intravenous supplementation (e.g., Potassium Phosphate / K-Phos) before administering concentrated calories. Initiate feeding at low rates while monitoring serum phosphorus, potassium, and magnesium daily.

• Metabolic and Glycemic Complications:

  • Hyperglycemia: High dextrose concentrations overwhelm endogenous insulin production. Monitor blood glucose every $4\text{ to }6\,\text{hours}$ in both diabetic and non-diabetic patients. Regular human insulin may be compounded directly into the PN bag by the pharmacy, paired with subcutaneous sliding-scale coverage.

  • Hypoglycemia: Occurs if the infusion is interrupted abruptly or if the endocrine pancreas hypersecretes insulin in response to high glucose loads.

  • Hyperlipidemia: Results from impaired clearance of intravenous fat emulsions; monitor serum triglyceride panels regularly.

  • Hepatic and Biliary Dysfunction: Long-term parenteral nutrition leads to steatosis, cholestasis, and cirrhosis. Monitor liver function tests (AST, ALT, alkaline phosphatase, total bilirubin).

  • Renal Impairment: High protein concentrations increase solute loads; monitor blood urea nitrogen (BUN) and serum creatinine daily.

• Central Venous Access Device (CVAD) Mechanical Complications:

  • Insertion Complications: Pneumothorax, hemothorax, hydrothorax, arterial puncture, and air embolism. Routine post-insertion chest radiography confirms proper SVC tip placement and rules out pleural injury.

  • Catheter-Related Venous Thrombosis: Formation of an intraluminal or pericatheter thrombus within the great central veins, manifested by ipsilateral edema of the neck, face, shoulder, or arm, alongside collateral venous distention.

  • Catheter Occlusion: High glucose concentrations cause intraluminal stickiness. Nurses should maintain line patency by routinely flushing central line ports with normal saline every $4\text{ to }8\,\text{hours}$ per institutional protocol.

  • Air Embolism Prevention: Ensure all Luer connections are secure, clamp catheters during cap changes, and instruct the patient to perform the Valsalva maneuver during catheter removal.

• Infectious Complications and CLABSI:

  • Central Line-Associated Bloodstream Infection (CLABSI): Highly concentrated dextrose and amino acid solutions serve as optimal growth media for bacterial and fungal pathogens (Staphylococcus aureus, Candida albicans).

  • Local Catheter Site Infections: Manifested by erythema, swelling, warmth, tenderness, induration, and purulent exudate at the skin insertion site.

  • Systemic Sepsis: Manifested by spiking fevers, rigors, diaphoresis, unexplained leukocytosis, tachycardia, tachypnea, and hypotension.

  • Clinical Management: If catheter sepsis is suspected, draw simultaneous blood cultures from the peripheral vasculature and directly from the central line lumen, discontinue the PN solution, disconnect tubing, and await orders regarding catheter removal or exchange.

Questions and Discussion

• Student Inquiry Regarding Materials: Did you just post this? Is it working for you?

  • Response: Yes, the materials were just uploaded. If an operation error occurs, refresh the browser. Both the nutritional problems handout and the previously posted accessory organ handout are confirmed visible and active.

• Student Inquiry Regarding Starvation Inflammation: Is systemic inflammation secondary to underlying illnesses, or is it directly caused by the malnutrition process itself?

  • Response: Systemic inflammation is directly caused by the malnutrition and starvation process itself. Following the rapid depletion of hepatic glycogen stores ($8\text{ to }18\,\text{hours}$), the human body is forced to catabolize adipose tissue and structural skeletal muscle. The massive breakdown of lean muscle and physiological stores activates a cytokine cascade, shifting the body into a hypermetabolic, inflammatory state marked by elevated C-Reactive Protein (CRP) and erythrocyte sedimentation rates.

• Student Inquiry Regarding Post-Surgical Malabsorption: Does the risk of malabsorption syndrome apply specifically to bariatric gastric bypass surgery?

  • Response: Yes, gastric bypass is a major cause of malabsorption syndrome. Bariatric bypass significantly reduces functional gastric volume and bypasses the duodenum and proximal jejunum, drastically reducing the absorptive mucosal surface area. These patients suffer from chronic nutrient absorption impairments and require lifelong oral and parenteral micronutrient supplementation.

• Student Inquiry Regarding Bolus Feeding Intolerance: What does it mean if a patient becomes "herpy" during a bolus enteral feeding?

  • Response: "Herpy" describes signs of gastrointestinal intolerance during or immediately after a feeding, including nausea, retching, severe fullness, or the urge to vomit. If these signs occur, the nurse must immediately stop the bolus feeding, allow the patient to rest, and obtain a medical order to decrease the delivery rate or convert from bolus administration to a continuous pump infusion.

• Student Inquiry Regarding Procedural Pause of Tube Feedings: Does the nurse require a specific physician order to stop an enteral feeding, flush the line, and transport a patient off the unit for a diagnostic procedure?

  • Response: No. A physician's order is not required to pause feeding for transport or patient turning. Stopping the feeding, flushing the line with water, and placing the tube on hold when the head of the bed must be lowered is an independent nursing action required to prevent aspiration. The feeding is resumed per original orders once the patient returns and the head of the bed is safely re-elevated to $30\text{ to }45^\circ$.

• Student Inquiry Regarding the Salem Sump Blue Vent Cap: Should the blue vent cap of a Salem Sump tube ever be removed or capped off when disconnecting from wall suction?

  • Response: No. The blue vent cap must never be removed from the Salem Sump. Inside the blue lumen is a one-way filter allowing atmospheric air to enter the stomach to prevent the suction ports from adhering to and damaging the gastric lining. To close the tube off from suction for ambulation, utilize the white plastic connector plug on the main suction tube to seal the primary suction port, leaving the blue vent open to the air.

• Student Inquiry Regarding Accidental G-Tube Dislodgement: If a gastrostomy tube is accidentally pulled out by a disoriented patient, should the nurse attempt to insert a new gastrostomy tube back into the tract?

  • Response: No. Reinserting a gastrostomy tube is outside the scope of nursing practice. However, because gastric stomas begin closing within hours, the nurse should immediately insert a sterile Foley catheter through the stoma into the stomach, inflate the balloon with sterile water, secure the catheter with tape without tension to preserve the tract, and contact the physician for formal tube replacement.

• Student Inquiry Regarding Small Bowel Obstruction Management: If a patient presents with a small bowel obstruction, is parenteral nutrition indicated?

  • Response: Yes. A small bowel obstruction impairs the gut and serves as an indication for parenteral nutrition. The patient remains strictly NPO to rest the bowel, receiving IV nutrition until the obstruction resolves and bowel motility returns, after which low-rate enteral "trickle feeds" may be initiated to stimulate the gut mucosal lining.

• Student Inquiry Regarding Gastric Residual Volumes and Refeeding: Must nurses always refeed all aspirated gastric residual volumes back into the patient, even if the measured volume exceeds 250 or 500 mL?

  • Response: Yes, standard clinical practice mandates refeeding the aspirate back into the patient's stomach to conserve vital digestive acids and electrolytes, preventing metabolic alkalosis and electrolyte depletion. However, if the volume exceeds $250\,\text{mL}$, the nurse reinstills the aspirate, holds the upcoming feeding, and notifies the provider for evaluation. The residual is only discarded if the aspirate is visibly foul, purulent, or if the patient is actively vomiting.

• Student Inquiry Regarding Intravenous Lipid Allergies: What action must be taken if a patient requiring parenteral nutrition exhibits an allergy to IV fat emulsions?

  • Response: Intravenous lipid emulsions are manufactured from refined soybean oil and egg phospholipids. If a patient possesses a documented soy or egg allergy, lipids must be withheld and the provider notified. The medical team will investigate alternative lipid formulations or evaluate antihistamine pretreatment, though soy-free options are prioritized.